Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gynecology
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    May 2024
  1. LUDWIG M, Taunk N, Chino J, Hathout L, et al
    Moving Toward Personalized Medicine in Gynecologic Cancers.
    Int J Radiat Oncol Biol Phys. 2024;119:1-5.
    >> Share

  2. COLSON-FEARON D, Han K, Roumeliotis MB, Viswanathan AN, et al
    Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
    Int J Radiat Oncol Biol Phys. 2024;119:154-162.
    >> Share

    March 2024
  3. CHOW Z, Fabian D
    Cervical Cancer With Vaginal Recurrence and Prior Pelvic Radiation.
    Int J Radiat Oncol Biol Phys. 2024;118:886-887.
    >> Share

  4. GEORGE J, Tuli S, Patel PP, Monare B, et al
    Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019).
    Int J Radiat Oncol Biol Phys. 2024 Mar 8:S0360-3016(24)00354.
    >> Share

  5. MEI X, Kok HP, Rodermond HM, van Bochove GGW, et al
    Radiosensitization by Hyperthermia Critically Depends on the Time Interval.
    Int J Radiat Oncol Biol Phys. 2024;118:817-828.
    >> Share

  6. FIELDS EC, Erickson B, Hubbard A, Chino J, et al
    Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142.
    Int J Radiat Oncol Biol Phys. 2024;118:869.
    >> Share

    February 2024
  7. HOWELL KJ, Jain A
    Endometrial Cancer Treatment: Long-Term Engagement Strategies.
    Int J Radiat Oncol Biol Phys. 2024;118:321.
    >> Share

  8. GLASER S
    Nodal Recurrence of Uterine Cancer: A Growing Problem.
    Int J Radiat Oncol Biol Phys. 2024;118:319.
    >> Share

  9. KASSICK M, Taunk NK
    Pelvic Nodal Recurrence in Uterine Cancer: Novel Management and a Radiation Riddle.
    Int J Radiat Oncol Biol Phys. 2024;118:318.
    >> Share

    January 2024
  10. HATHOUT L, Sherwani ZK, Alegun J, Ohri N, et al
    Prognostic impact of mismatch repair status in early-stage endometrial cancer treated with adjuvant radiation: a multi-institutional analysis.
    Int J Radiat Oncol Biol Phys. 2024 Jan 20:S0360-3016(24)00247.
    >> Share

    December 2023
  11. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Patient experiences of brachytherapy for locally advanced cervical cancer: hearing the patient voice through qualitative interviews.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08253.
    >> Share

  12. MANTZ C
    Comments on "Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy".
    Int J Radiat Oncol Biol Phys. 2023;117:1143-1144.
    >> Share

  13. FIELDS EC, Erickson B, Chino J, Small C, et al
    Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:1138-1142.
    >> Share

    November 2023
  14. AKINFENWA CA, Allanson E, Ewongwo A, Lumley C, et al
    Mapping of radiation oncology and gynecologic oncology services available to treat the growing burden of cervical cancer in Africa.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08043.
    >> Share

  15. CORBEAU A, Heemsbergen WD, Kuipers SC, Godart J, et al
    Predictive factors for toxicity after primary chemoradiation for locally advanced cervical cancer: a systematic review.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08133.
    >> Share

  16. HAN K, Colson-Fearon D, Liu ZA, Viswanathan A, et al
    Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08132.
    >> Share

    October 2023
  17. DUPERE JM, Lucido JJ, Breen WG, Mahajan A, et al
    Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953.
    >> Share

  18. GHOSH DS, Gurram DL, Kumar DA, Mulye DG, et al
    Clinical implementation of 'plan of the day' strategy in definitive radiotherapy of cervical cancer: Online adaptation to address the challenge of organ filling reproducibility.
    Int J Radiat Oncol Biol Phys. 2023 Oct 8:S0360-3016(23)07956.
    >> Share

  19. HAN K, Leung E
    Opinion "POLE": Considering All Factors in Early-Stage Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:299-300.
    >> Share

  20. MATANI H, Beriwal S
    Interplay Between Anatomic and Molecular Factors in the Current Management of Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:298.
    >> Share

    September 2023
  21. KUNZ JN, Huang YJ, Casper AC, Suneja G, et al
    Dosimetric Evaluation of Organs at Risk From SAVE Protocol.
    Int J Radiat Oncol Biol Phys. 2023;117:274-280.
    >> Share

  22. CHO WK, Kim HS, Park W, Kim YS, et al
    The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
    Int J Radiat Oncol Biol Phys. 2023;117:154-163.
    >> Share

    August 2023
  23. COLSON-FEARON D, Stone R, Viswanathan AN
    Risk factors and survival impact associated with documentation of radiation therapy refusal in gynecologic cancer patients.
    Int J Radiat Oncol Biol Phys. 2023 Aug 30:S0360-3016(23)07851.
    >> Share

  24. LAVILLE A, Ka K, El-Ayachi R, Achkar S, et al
    Locoregional treatment in patients with metastatic cervical cancer: benefit of dose escalation strategies.
    Int J Radiat Oncol Biol Phys. 2023 Aug 14:S0360-3016(23)07744.
    >> Share

    July 2023
  25. KUMAR A, Gurram L, Nayak P, Mulye G, et al
    Correlation of haematological parameters with clinical outcomes in cervical cancer patients treated with radical radio (chemo) therapy - A retrospective study.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07677.
    >> Share

    June 2023
  26. LIN LL, Msadabwe SC, Chiao E
    Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2023;116:459-462.
    >> Share

  27. LIN LL, Ndlovu N, Lowenstein J, Wirth M, et al
    Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
    Int J Radiat Oncol Biol Phys. 2023;116:439-447.
    >> Share

    May 2023
  28. MACCHIA G, Pezzulla D, Campitelli M, Laliscia C, et al
    EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC UTERINE CANCER (MITO-RT2/RAD STUDY): A LARGE, REAL-WORLD STUDY IN COLLABORATION WITH AIRO GYN, MITO and MaNGO Groups.
    Int J Radiat Oncol Biol Phys. 2023 May 5:S0360-3016(23)00417.
    >> Share

    April 2023
  29. MARAR M, Niedermayr T, Kidd E
    Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency.
    Int J Radiat Oncol Biol Phys. 2023 Apr 12:S0360-3016(23)00364.
    >> Share

  30. LI B, Hirata E, Trejo JM, Garcia B, et al
    Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2023;115:1205-1216.
    >> Share

    March 2023
  31. KOK HP, Herrera TD, Crezee J
    The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
    Int J Radiat Oncol Biol Phys. 2023;115:994-1003.
    >> Share

  32. PIFER PM, Jaishankar S, Bhargava R, Schad MD, et al
    Is substantial LVSI prognostic in patients with pathologically lymph node-negative endometrial cancer?
    Int J Radiat Oncol Biol Phys. 2023 Mar 7:S0360-3016(23)00214.
    >> Share

    February 2023
  33. SAMMOURI J, Wong MC, Lynn EJ, El Alam MB, et al
    Serial genotyping of the human papillomavirus in cervical cancer: an insight into virome dynamics during chemoradiation therapy.
    Int J Radiat Oncol Biol Phys. 2023 Feb 16:S0360-3016(23)00163.
    >> Share

  34. HATHOUT L, Fields EC, Erickson BA
    Stereotactic Body Radiation Therapy for Nodal Metastases in Gynecologic Cancers: Is it the Swan Song or the Opening Number?
    Int J Radiat Oncol Biol Phys. 2023;115:297-301.
    >> Share

  35. CORRADINI S, Seidensticker M
    "New" Kid on the Block: Interstitial Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;115:277-279.
    >> Share

  36. HARKENRIDER M, Fields E, Chopra S, Damast S, et al
    Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:269-275.
    >> Share

    January 2023
  37. ARIANS N, Lindel K, Krisam J, Oelmann-Avendano JT, et al
    Treatment tolerability and toxicity of postoperative proton beam therapy for gynecological malignancies - results of the prospective phase II APROVE-trial.
    Int J Radiat Oncol Biol Phys. 2023 Jan 12:S0360-3016(23)00012.
    >> Share

  38. VITTRUP AS, Kirchheiner K, Potter R, Fokdal LU, et al
    Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00007.
    >> Share

    November 2022
  39. JIANG P, Deng X, Qu A, Jiang W, et al
    Image-guidance volume modulated arc radiotherapy concurrently with Nab-paclitaxel plus cisplatin for patients with locally advanced cervical cancer: a single-arm dose escalation trial.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03522.
    >> Share

  40. MA J, Lee NY
    What to Expect When You're Expecting: Managing Oral Cavity Cancer in the Setting of a Second Trimester Pregnancy.
    Int J Radiat Oncol Biol Phys. 2022;114:383-384.
    >> Share

  41. SHARMA AK
    Adjuvant Head and Neck Radiation in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022;114:382.
    >> Share

    October 2022
  42. YODER AK, Dong E, Yu X, Echeverria A, et al
    Impact of Quality of Life on Radiation Adherence for Cervical Cancer Patients in an Urban Safety Net Health System.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03439.
    >> Share

    September 2022
  43. KAMRAVA M, Leung E, Bachand F, Beriwal S, et al
    GEC-ESTRO (ACROP) - ABS - CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.
    Int J Radiat Oncol Biol Phys. 2022 Sep 30. pii: S0360-3016(22)03396.
    >> Share

  44. MARAR M, Simiele E, Niedermayr T, Kidd EA, et al
    Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
    Int J Radiat Oncol Biol Phys. 2022;114:111-119.
    >> Share

    August 2022
  45. JACOBSON GM, Bajaj GK, Buatti JM, Dawson L, et al
    ASTRO supports access to evidence-based cancer care for all patients, regardless of pregnancy status, and protection for physicians recommending and providing evidence-based care.
    Int J Radiat Oncol Biol Phys. 2022 Aug 9. pii: S0360-3016(22)02602.
    >> Share

  46. CHINO J, Yashar C, Klopp A, Viswanathan A, et al
    Limiting Access to Abortion will Potentially Harm Patients with Gynecologic Cancers.
    Int J Radiat Oncol Biol Phys. 2022 Aug 9. pii: S0360-3016(22)02600.
    >> Share

  47. EVANS SB, Blitzblau RC, Chapman CH, Lipscomb CC, et al
    Restricted Access to Abortion, the Dobbs Ruling, and Radiation Oncology: Standing United Against Reproductive Injustice.
    Int J Radiat Oncol Biol Phys. 2022 Aug 9. pii: S0360-3016(22)02598.
    >> Share

  48. MULANI J, Jain J, Gupta A, Swamidas J, et al
    Dose Accumulation for Multicourse Gynecological Reirradiation: A Methodological Narrative and Clinical Examples.
    Int J Radiat Oncol Biol Phys. 2022;113:1085-1090.
    >> Share

    July 2022
  49. BARRY P, Beriwal S
    Combination of Knife and Rays with MRI-Guided Ablative Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2022;113:717-718.
    >> Share

  50. CHOPRA S, Kalra B, Mulani J, Jain J, et al
    Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00722.
    >> Share

    June 2022
  51. GOUVEIA AG, Viani GA, Bratti VF, Pavoni JF, et al
    System-level capacity of high dose rate (HDR) brachytherapy for management of cervical cancer in an upper middle-income country: a case study from Brazil.
    Int J Radiat Oncol Biol Phys. 2022 Jun 29. pii: S0360-3016(22)00624.
    >> Share

  52. RICH BJ, Montoya C, Jin WH, Spieler BO, et al
    Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 4. pii: S0360-3016(22)00545.
    >> Share

    March 2022
  53. KIDD E, Harkenrider M, Damast S, Fields E, et al
    Improving Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:841-848.
    >> Share

    February 2022
  54. MITTAL P, Chopra S, Charnalia M, Dora T, et al
    Patterns of relapse after adjuvant (chemo)radiation for cervical cancer in a phase III clinical trial (PARCER): an evaluation of updated NRG Oncology /RTOG target delineation guidelines.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00153.
    >> Share

  55. LINDEGAARD JC, Petric P, Schmid MP, Nesvacil N, et al
    Prognostic implications of uterine cervical cancer regression during chemoradiation evaluated by the T-score in the multicenter XXX study.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00151.
    >> Share

  56. DAMAST S, Chino J
    Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:414-416.
    >> Share

    January 2022
  57. WILLIAMSON CW, Sirak I, Xu R, Portelance L, et al
    Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.
    Int J Radiat Oncol Biol Phys. 2022;112:169-178.
    >> Share

    November 2021
  58. SMET S, Spampinato S, Potter R, Jurgenliemk-Schulz IM, et al
    Risk factors for late persistent fatigue after chemoradiotherapy in locally advanced cervical cancer: an analysis from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03220.
    >> Share

  59. WANG X, Ouyang G, Chen Z, Fu L, et al
    Automatic Contouring of the Clinical Target Volume (CTV) for Cervical Cancer Adjuvant Radiotherapy Using Deep Learning Algorithm.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  60. KAWAHARA D, Nishibuchi I, Kawamura M, Yoshida T, et al
    Radiomic Analysis for Pretreatment Prediction of Recurrence after Radiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  61. HAMADE DF, Epperly M, Fisher R, Hou W, et al
    Second-Generation Probiotic Lactobacillus Reuteri Producing IL-22 (LR-IL-22) Protects the Intestine to Facilitate Whole Abdomen Irradiation (WAI) in Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  62. YU E, DiPetrillo TA, Koffer PP, Miller CJ, et al
    Hospital Database Validation of PORTEC3 Stage-Based Overall Survival Benefit for Chemoradiation Therapy in Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  63. WEIL C, Lew F, Gaffney DK, Suneja G, et al
    Patterns of Practice for Adjuvant Treatment of FIGO 1B Grade 3 Endometrial Adenocarcinoma Following Publication of ASTRO 2014 Guidelines for Postoperative Treatment in Women With Early Stage High Risk Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  64. WANG W, Zou L, Wang T, Liu Z, et al
    Treatment Optimization of Pelvic External Beam Radiation With/or Vaginal Brachytherapy for Patients with Stage I to II High-Risk Endometrioid Adenocarcinoma: A Retrospective Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  65. SUN S, Zou L, Wang T, Liu Z, et al
    Age >/=60 y May Not be an Appropriate Adverse Risk Factor in Adjuvant Treatment of Patients With Early-Stage Endometrial Carcinoma: A Multi-Institutional Analysis in China.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  66. RUSSO AL, Bernstein KD, Nisbet SP, Horick N, et al
    Phase II Study of Adjuvant Scanned Proton Beam Radiation Therapy for Node-positive Cancer of the Uterus and Cervix.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  67. REN K, Zou L, Wang T, Li X, et al
    Long-Term Outcome and Failure Patterns in Early-Stage Endometrial Cancer After Postoperative Adjuvant Radiotherapy: A Multi-Institutional Analysis Update Data.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  68. PATEL G, Rivera A, Brodin P, Velten C, et al
    Outcomes of Definitive Radiation Therapy for Inoperable Endometrial Cancer and Dosimetric Comparison Study of HDR Brachytherapy vs. SBRT Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  69. NGANGA D, Hoover A
    Visceral Adipose Volume as a Predictor for Acute Bowel Toxicity in Patients Receiving Adjuvant Intensity-Modulated Radiation Therapy for Cervical or Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  70. IKIZLER O, Ko HC
    Outcomes after Definitive Surgery +/- Adjuvant Treatment for Invasive and Non-Invasive FIGO Stage IA Malignant Mixed Mullerian Tumor of the Endometrium.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  71. HUI C, Mendoza M, Von Eyben R, Hammer P, et al
    Does Lymph Node Assessment Change the Prognostic Significance of Extensive LVSI and p53 Mutation in Endometrial Cancer?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  72. MERFELD E, Huang JY, Kuczmarska-Haas A, Desai V, et al
    Targeting the GTV in Medically Inoperable Endometrial Cancer Using Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  73. COOK AE, Ghanem AI, Hijaz M, Burmeister C, et al
    Patterns of Recurrence After Adjuvant Vaginal Cuff Brachytherapy and Chemotherapy in Early-Stage Uterine Serous Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  74. BYLUND KC, Chowdhry AK, Nguyen K, Geevarghese S, et al
    Effect of Adjuvant Radiation and Chemotherapy in Localized Uterine Carcinosarcoma: A National Cancer Database Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  75. CASPER AC, Parsons MW, Chipman J, Burt LM Jr, et al
    Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-up.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  76. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
    Pathologic Primary Tumor Factors Associated With Risk of Lymph Node Involvement in Patients With High-Risk Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  77. POLLOCK AE, Risher H, Bentzen SM, Roque DM, et al
    Clinical Outcomes of Patients Treated With Intensity Modulated Proton Therapy (IMPT) Re-Irradiation for Gynecologic Malignancies.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  78. CORRIGAN KL, Yoder AK, Lin LL, Jhingran A, et al
    Long-Term Survival Following Definitive Radiation Therapy for Oligometastases in Gynecological Malignancies: A Landmark Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  79. ZHOU Z, Zhang F, Hu K
    High Dose Radiotherapy Combined With TGF-beta Blocking Alleviate Cervical Cancer Cell-Suppressed Dendritic Cell Homing Through PGE2 Pathway.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  80. AMARNATH SR
    Is Inflammatory Bowel Disease a Contraindication for Pelvic XRT in Patients With Gynecologic Cancers? Efficacy and Toxicity Outcomes in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  81. YANG H, Zhang Y, Liu C, Zhao L, et al
    Combined Modality of Bevacizumab With Radical Radiotherapy and Chemotherapy in the Treatment of Refractory Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  82. WU J, Lakomy DS, Fellman B, Salcedo MP, et al
    Bone Mineral Density Changes Within and Outside of RT Fields Used to Treat Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  83. WILLIAMSON CW, Kotha NV, Morris K, Simoes-Torigoe R, et al
    Radiation-Induced Vaginal Stenosis in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  84. WEIL C, Parsons MW, Chipman J, Kraus RD, et al
    Secondary Malignancy Risk in Cervical Cancer Survivors After 40 Years of Follow-Up Stratified by Treatment Modality and Radiation Technique.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  85. WANG D, Hu K, Zhang F
    Impact of Body Mass Index and Abdominal Subcutaneous Fat Thickness of Setup Errors in Postoperative Cervical Cancer Patients Underwent Daily Image-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  86. WEI C, Franco II, Orio PF 3rd, Mak RH, et al
    Comparison of Cost vs. Reimbursement for Definitive Radiotherapy in Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  87. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
    Trends in Guideline-Adherent Chemoradiation Therapy for Locally Advanced Cervical Cancer Before and After the Affordable Care Act.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  88. SAITO AI
    Curative Radiotherapy for Stage IVB or Recurrent Uterine Cancer Presenting With Supraclavicular or Mediastinal Lymph Node Metastasis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  89. SHI V, Huang Y, Grigsby PW, Markovina S, et al
    Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  90. RAHIMY E, Von Eyben R, Lewis J, Hristov DH, et al
    Dosimetric and Metabolic Parameters Predictive of Hematologic Toxicity in Cervical Cancer Patients Undergoing Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  91. PINTO PJJ, Favareto SL, Souza CFPM, Baiocchi G, et al
    Do Radiotherapy Planning Factors Influence Para-Aortic Recurrence in IIIC1 Cervical Cancer Patients?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  92. PACHIGOLLA SL, Markovina S, Lin AJ, Schwarz JK, et al
    Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  93. ONAL C, Guler OC, Reyhan M, Yapar AF, et al
    Long-Term Outcomes of Cervical Cancer Patients With Complete Metabolic Response After Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  94. PACHIGOLLA SL, Massad LS, Thaker P, Mutch D, et al
    A Nomogram Predicting Early Cervical Cancer Distant Recurrence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  95. OKONOGI N, Ando K, Murata K, Wakatsuki M, et al
    The Clinical Results in Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients With Locally Advanced Adenocarcinoma of the Uterine Cervix.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  96. NISHIBUCHI I, Kawahara D, Kawamura M, Kubo K, et al
    A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  97. PUENTES CYM, Banks T, Hrycushko BA, Jia X, et al
    Multidisciplinary Consensus and Evaluation of Gynecological High-Dose-Rate (HDR) Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  98. LIU C, Li A, Wang C, Zou W, et al
    Intratumor Microbiome and Its Correction With Tumor Response After Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  99. LI F, Li J, Yin S, Mei F, et al
    A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump >/=4 cm).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  100. LI J, Mao W, Li F, Ran L, et al
    A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  101. KOTHA NV, Williamson CW, McHale M, Mell LK, et al
    Ineligible and Incomplete Cisplatin Regimens in Chemoradiation Treatment for Patients With Locally Advanced Cervical Cancer: A Population for Survival Improvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  102. LEE TH, Kim IA, Kim JS Jr, Song C, et al
    Stereotactic Ablative Body Radiotherapy Boost for Cervical Cancer When Brachytherapy Boost is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  103. KIM KH, Chang JS, Kim YB
    A Novel Gene Signature Associated With Poor Response to Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  104. KOERNER SA, Baig T, Kim H, Rodriguez-Lopez JL, et al
    Can We Avoid Ureters as Organs at Risk With MRI-Based Brachytherapy for Cervical Cancer? A Dosimetric Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  105. GJYSHI O, Grippin A, Boyce-Fappiano D, Jhingran A, et al
    Circulating and Tumor-Associated Neutrophils Function as a Powerful Biomarker for Response to Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  106. HOLLIS ES, Ruebush E, Davies E, Paraghamian S, et al
    Smoking Cessation Interventions During Chemoradiotherapy for Locally Advanced Cervical Cancer: A Missed Opportunity?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  107. GEORGE J, Tuli S, Monare B, Lichter K, et al
    Stage and Outcomes of Cervical Cancer With or Without HIV Infection in Botswana 2013-2020.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  108. FREIJE S, Steele EM, Robertson SE, Ishaq O Jr, et al
    Medicaid Expansion Through the Affordable Care Act and Receipt of Guideline Recommended Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  109. DING S, Liu H, Wang B, Li Y, et al
    Inter- and Intrafraction Bladder and Rectum Motion in Patients With Cervical Cancer Under MR-Guided Radiotherapy on a 1.5T MR-Linac.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  110. COUSINS DF, Sanders J, Muller DA, Ward KA, et al
    Disease Characteristics and Patterns of Failure by Histologic Type for Patients Treated With Definitive Radiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  111. D'CUNHA P, Gonzalez Y, Nwachukwu CR, Hrycushko BA, et al
    Change in Image-Guided Planning Strategies Over Time Impacts Global Outcomes for Intracavitary Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  112. MORCOS M, Bhatia R, Li K, Viswanathan AN, et al
    Prospective Trial of Hydrogel Visualization and Dosimetric Effects on Rectum and Tumor Dose in Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  113. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Toxicity Related Patients Factors and Bevasizumab Use in Patients With Locally Advanced Cervical Cancer Treated With Definitive Chemoradiation and HDR Brachytherapy Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  114. CHEN Y, Sun C, Li Q, Tang H, et al
    The Effect of Bulk Electron Density on the Accuracy of Treatment Planning for Postoperative Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  115. CHOQUE R, Aviles L, Rosas M, Suarez R, et al
    PET CT Based Stereotactic Body Radiosurgery (SBRT) in Non-Metastatic Cervical Cancer. The First Bolivian Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  116. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Racial Disparities in Time to Start of Definitive Radiation Treatment for Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  117. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Disparities and Health Access in Brachytherapy Boost Administration in Woman With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  118. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
    Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  119. SHIAO JC, Santoso A, Stuhr K, Bennett S, et al
    Gynecologic Interstitial Brachytherapy Curriculum Using a Low-Cost Phantom With Ultrasound Workshop and a Treatment Planning Workshop is Feasible and Effective.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  120. ORIAN IB, Symon Z, Appel S, Nof EL, et al
    The Impact of Radiation Therapy on Obstetric Complications in Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  121. URBAN R, Wong J, Lim P, Zhang S, et al
    Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  122. TARIQ M, Denniston KA
    EQD2 Dose Accumulation Based on Deformable Image Registration of HR-CTV, Bladder, Rectum and Bowel for Combined External-Beam Radiotherapy and Brachytherapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  123. GAY C, Raphael Y, Steers J, Lu DJ, et al
    Ovarian Transposition Prior to Pelvic Radiotherapy: Spatial Distribution and Dose Volume Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  124. YEN A, Morgan HE, Wang K, Albuquerque KV, et al
    Interpretable Machine Learning Model Supported by Parallel Ensemble Learning to Predict Local Recurrence for Patients with Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  125. REIJTENBAGH DMW, Godart J, De Leeuw A, Seppenwoolde Y, et al
    A Machine-Learning Based Method for Inter-Institutional QA of MR-Based Brachytherapy Treatment Planning in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  126. LIU C, Wang C, Hu X, Zou W, et al
    Dissecting Concurrent Chemoradiotherapy-Induced Landscape Alteration of Tumor Microenvironment in Locally Advanced Cervical Cancer at Single Cell Resolution.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  127. WANG W, Hu K, Zhang F
    Prophylactic Extended-Field Irradiation vs. Pelvic Irradiation in Cervical Cancer Patients With 2018 FIGO IIIC1 Diseases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  128. HAN K, Fyles TW, Shek T, Croke JM, et al
    Chemoradiation With or Without Metformin in Locally Advanced Cervical Cancer: Phase II Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  129. ROBIN TP, Hu J, Jones BL, Patton TJ, et al
    Phase I Dose Escalation Clinical Trial of Stereotactic Body Radiation Therapy (SBRT) for Limited Locoregional Recurrences of Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  130. LEUNG EW, Gladwish AP, Davidson MTM, Taggar A, et al
    Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus (SPARTACUS): A Multicenter Prospective Trial Evaluating Acute Toxicities and Patient Reported Outcomes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  131. ZHANG Y, Liu C, Yang H, Shi M, et al
    Weekly Cisplatin vs. Triweekly Docetaxel Plus Cisplatin With Concurrent Chemoradiation in Post-Operative Treatment for Cervical Cancer With High-Risk Pathological Factors: A Randomized Controlled Phase III Trial From a Single Institution.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  132. ROGACKI K, Wray B, Donnelly ED
    Gene Expression and Mutation Analysis of Early-Stage Recurrent Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  133. LI JY, Park HSM, Huang G, Young MR, et al
    Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  134. LAKOMY DS, Wu J, Yoder AK, Hernandez M, et al
    Impact of Treatment Modality on Pelvic Floor Dysfunction for Uterine Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  135. DONOVAN E, Albuquerque KV, Mantz CA, Beriwal S, et al
    The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  136. ROVIROSA A SR, Zhang Y, Chargari C, Cooper R, et al
    3D Image-Guided Brachytherapy as Only Treatment for Stage-I Inoperable Endometrial Cancer: Retrospective Analysis of the Gynecological Cancer GEC-ESTRO Working Group.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  137. NDUMBALO J, Muya S, Nyagabona SK, Yusuph S, et al
    Continuing Education Needs Identified During the Initial Experience of Delivering 3D Conformal Radiotherapy for Cervical Cancer Patients in Tanzania.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  138. YANEY A, Mladkova N, Quick AM
    Clinical and Genomic Determinants of Survival in Ugandan Women With Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  139. BHATIA R, Ramogola-Masire D, Friebel-Klingner T, Monare B, et al
    Cervical Cancer Screening in Botswana: An Urgent Call for Guideline Change.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

    October 2021
  140. SPAMPINATO S, Jensen NBK, Potter R, Fokdal LU, et al
    Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future.
    Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02915.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016